Serveur d'exploration Tocilizumab - Analysis (France)

Index « Auteurs » - entrée « Stéphanie Rouanet »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Stéphanie Rist < Stéphanie Rouanet < Stéphanie Seguin-Py  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000113 (2019) Alexandre Virone [France] ; Jean-Philippe Bastard [France] ; Soraya Fellahi [France] ; Jacqueline Capeau [France] ; Stéphanie Rouanet [France] ; Jean Sibilia [France] ; Philippe Ravaud [France] ; Francis Berenbaum [France] ; Jacques-Eric Gottenberg [France] ; Jérémie Sellam [France]Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis
000379 (2015) Karine Briot [France] ; Stéphanie Rouanet [France] ; Thierry Schaeverbeke [France] ; Fabien Etchepare [France] ; Philippe Gaudin [France] ; Aleth Perdriger [France] ; Muriel Vray [France] ; Ghislaine Steinberg [France] ; Christian Roux [France]The effect of tocilizumab on bone mineral density, serum levels of Dickkopf-1 and bone remodeling markers in patients with rheumatoid arthritis.
000751 (????) Alain Saraux [France] ; Stéphanie Rouanet [France] ; René-Marc Flipo [France] ; Jean-Cyril Poncet [France] ; Patrice Fardellone [France] ; Pascal Hilliquin [France] ; Isabelle Idier [France] ; Alain Cantagrel [France]Glucocorticoid-sparing in patients suffering from rheumatoid arthritis and treated with tocilizumab: the SPARE-1 study.

List of associated KwdEn.i

Nombre de
documents
Descripteur
3Antibodies, Monoclonal, Humanized (therapeutic use)
3Arthritis, Rheumatoid (drug therapy)
3Female
3Humans
3Male
3Middle Aged
2Adult
2Aged
2Biomarkers (blood)
1Abatacept (therapeutic use)
1Adiponectin (metabolism)
1Anti-Inflammatory Agents (pharmacology)
1Anti-Inflammatory Agents (therapeutic use)
1Antibodies, Monoclonal, Humanized (pharmacology)
1Antirheumatic Agents (therapeutic use)
1Apolipoprotein A-I (drug effects)
1Apolipoprotein B-100 (drug effects)
1Arthritis, Rheumatoid (complications)
1Arthritis, Rheumatoid (metabolism)
1Biological Factors (therapeutic use)
1Biological Products (pharmacology)
1Biological Products (therapeutic use)
1Bone Density (drug effects)
1Bone Remodeling (drug effects)
1Cardiovascular Diseases (blood)
1Collagen Type I (blood)
1Double-Blind Method
1Glucocorticoids (pharmacology)
1Glucocorticoids (therapeutic use)
1Insulin Resistance (physiology)
1Intercellular Signaling Peptides and Proteins (blood)
1Interleukin-6 (antagonists & inhibitors)
1Leptin (metabolism)
1Lipoprotein(a) (drug effects)
1Methotrexate (therapeutic use)
1Prednisone (therapeutic use)
1Prospective Studies
1Risk Factors
1Rituximab (therapeutic use)
1Tumor Necrosis Factor Inhibitors (therapeutic use)
1adipokine
1apolipoprotein
1biological agents
1cardiovascular risk
1rheumatoid arthritis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Stéphanie Rouanet" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Stéphanie Rouanet" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Stéphanie Rouanet
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021